Company research
UNITEDHEALTH GROUP INC
CIK 731766Updated Sep 26, 2026
SecurityUNH · NYSE · equity
Name history
UNITED HEALTHCARE CORP · through Feb 14, 2000
UNH price & chart
Loading TradingView…
NYSE:UNH on TradingView ↗In the news
UnitedHealth Group Incorporated Investor Alert (NYSE: UNH): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors Following DOJ Probe and for Possible False Statements News provided by Schubert Jonckheer & Kolbe LLP Jun 26, 2025, 11:00 ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 309,581,000,000Source | 298,278,000,000Source | 273,720,000,000Source | 245,705,000,000Source |
| Property, Plant and Equipment, NetUSD | 10,762,000,000Source | 10,553,000,000Source | 11,450,000,000Source | 10,128,000,000Source |
| GoodwillUSD | 110,499,000,000Source | 106,734,000,000Source | 103,732,000,000Source | 93,352,000,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 20,474,000,000Source | 23,268,000,000Source | 15,194,000,000Source | 14,401,000,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 24,365,000,000Source | 25,312,000,000Source | 25,427,000,000Source | 23,365,000,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 23,018,000,000Source | 22,365,000,000Source | 21,276,000,000Source | 17,681,000,000Source |
| Inventory, NetUSD | 3,300,000,000Source | 3,800,000,000Source | 2,800,000,000Source | 3,500,000,000Source |
| Assets, CurrentUSD | 90,582,000,000Source | 85,779,000,000Source | 78,437,000,000Source | 69,069,000,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 9,746,000,000Source | 8,212,000,000Source | 6,084,000,000Source | 6,621,000,000Source |
| Other Assets, NoncurrentUSD | 23,013,000,000Source | 19,590,000,000Source | 17,298,000,000Source | 15,027,000,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 207,883,000,000Source | 195,687,000,000Source | 174,801,000,000Source | 159,358,000,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 9,000,000Source | 9,000,000Source | 9,000,000Source | 9,000,000Source |
| Additional Paid in CapitalUSD | 559,000,000Source | — | — | — |
| Retained Earnings (Accumulated Deficit)USD | 95,603,000,000Source | 96,036,000,000Source | 95,774,000,000Source | 86,156,000,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -2,061,000,000Source | -3,387,000,000Source | -7,027,000,000Source | -8,393,000,000Source |
| Liabilities and EquityUSD | 309,581,000,000Source | 298,278,000,000Source | 273,720,000,000Source | 245,705,000,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 114,897,000,000Source | 103,769,000,000Source | 99,054,000,000Source | 89,237,000,000Source |
| Deferred Income Tax Liabilities, NetUSD | 2,421,000,000Source | 3,620,000,000Source | 3,021,000,000Source | 2,769,000,000Source |
| Other Liabilities, NoncurrentUSD | 18,245,000,000Source | 15,939,000,000Source | 14,463,000,000Source | 12,839,000,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 5,980,000,000Source | 5,610,000,000Source | 5,665,000,000Source | 3,678,000,000Source |
| Additional Financial Items | ||||
| Deferred Revenue, CurrentUSD | 3,413,000,000Source | 3,317,000,000Source | 3,355,000,000Source | 3,075,000,000Source |
| Deferred Tax Liabilities, NetUSD | 2,421,000,000Source | 3,620,000,000Source | 3,021,000,000Source | 2,769,000,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 72,320,000,000Source | 72,359,000,000Source | 58,263,000,000Source | 54,513,000,000Source |
| Redeemable Noncontrolling Interest, Equity, Carrying AmountUSD | 1,608,000,000Source | 4,323,000,000Source | 4,498,000,000Source | 4,897,000,000Source |
| Short-term InvestmentsUSD | 3,756,000,000Source | 3,801,000,000Source | 4,201,000,000Source | 4,546,000,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 12,807,000,000Source | 15,242,000,000Source | 23,144,000,000Source | 20,639,000,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation and amortization | — | — | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 971,000,000Source | 1,018,000,000Source | 1,059,000,000Source | 925,000,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 764,000,000Source | 1,437,000,000Source | 3,114,000,000Source | 2,523,000,000Source |
| Deferred Income Tax Expense (Benefit)USD | -1,752,000,000Source | -296,000,000Source | -245,000,000Source | -673,000,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 19,697,000,000Source | 24,204,000,000Source | 29,068,000,000Source | 26,206,000,000Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 4,509,000,000Source | 13,408,000,000Source | 10,136,000,000Source | 21,458,000,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -8,685,000,000Source | -20,527,000,000Source | -15,574,000,000Source | -28,476,000,000Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | 341,000,000Source | 1,667,000,000Source | 960,000,000Source | 793,000,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 3,622,000,000Source | 3,499,000,000Source | 3,386,000,000Source | 2,802,000,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 5,545,000,000Source | 9,000,000,000Source | 8,000,000,000Source | 7,000,000,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -11,644,000,000Source | -3,512,000,000Source | -11,529,000,000Source | 4,226,000,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 7,916,000,000Source | 7,533,000,000Source | 6,761,000,000Source | 5,991,000,000Source |
| Proceeds from (Payments for) Other Financing ActivitiesUSD | 63,000,000Source | -1,645,000,000Source | -1,150,000,000Source | -1,944,000,000Source |
| Repayments of Long-term DebtUSD | 3,050,000,000Source | 3,000,000,000Source | 2,125,000,000Source | 3,015,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -947,000,000Source | -115,000,000Source | 2,062,000,000Source | 1,990,000,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 24,365,000,000Source | 25,312,000,000Source | 25,427,000,000Source | 23,365,000,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 4,030,000,000Source | 3,594,000,000Source | 3,035,000,000Source | 1,945,000,000Source |
| Income Taxes Paid, NetUSD | 3,714,000,000Source | 4,620,000,000Source | 6,078,000,000Source | 5,222,000,000Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 40,000,000Source | -61,000,000Source | 97,000,000Source | 34,000,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,700,000,000Source | 1,700,000,000Source | 1,600,000,000Source | 1,300,000,000Source |
| Capitalized Computer Software, AmortizationUSD | 1,700,000,000Source | 1,400,000,000Source | 1,200,000,000Source | 1,000,000,000Source |
| Deconsolidation, Gain (Loss), AmountUSD | 1,700,000,000Source | — | — | — |
| DepreciationUSD | 1,000,000,000Source | 1,000,000,000Source | 1,100,000,000Source | 1,100,000,000Source |
| Gain (Loss) on Disposition of BusinessUSD | 910,000,000Source | 3,333,000,000Source | — | — |
| GoodwillUSD | 110,499,000,000Source | 106,734,000,000Source | 103,732,000,000Source | 93,352,000,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | 1,890,000,000Source | 4,829,000,000Source | 5,968,000,000Source | 5,704,000,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 313,995,000,000Source | 264,185,000,000Source | 241,894,000,000Source | 210,842,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 12,056,000,000Source | 14,405,000,000Source | 22,381,000,000Source | 20,120,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 751,000,000Source | 837,000,000Source | 763,000,000Source | 519,000,000Source |
| Payments to Acquire InvestmentsUSD | 17,373,000,000Source | 27,308,000,000Source | 18,314,000,000Source | 18,825,000,000Source |
| Proceeds from Issuance of Common StockUSD | 827,000,000Source | 1,846,000,000Source | 1,353,000,000Source | 1,253,000,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 2,969,000,000Source | 17,811,000,000Source | 6,394,000,000Source | 14,819,000,000Source |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-saleUSD | 8,446,000,000Source | 9,319,000,000Source | 9,230,000,000Source | 6,081,000,000Source |
| Restructuring CostsUSD | 2,500,000,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 447,567,000,000Source | 400,278,000,000Source | 371,622,000,000Source | 324,162,000,000Source |
| Cost of RevenueUSD | 50,655,000,000Source | 46,694,000,000Source | 38,770,000,000Source | 33,703,000,000Source |
| Gross Profit (Calculated) · Derived | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | 59,592,000,000Source | 53,013,000,000Source | 54,628,000,000Source | 47,782,000,000Source |
| Operating Income (Loss)USD | 18,964,000,000Source | 32,287,000,000Source | 32,358,000,000Source | 28,435,000,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 14,697,000,000Source | 20,071,000,000Source | 29,112,000,000Source | 26,343,000,000Source |
| Income Tax Expense (Benefit)USD | 1,890,000,000Source | 4,829,000,000Source | 5,968,000,000Source | 5,704,000,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 751,000,000Source | 837,000,000Source | 763,000,000Source | 519,000,000Source |
| Net Income (Loss) Attributable to ParentUSD | 12,056,000,000Source | 14,405,000,000Source | 22,381,000,000Source | 20,120,000,000Source |
| Earnings Per Share, BasicUSD per share | 13.28Source | 15.64Source | 24.12Source | 21.47Source |
| Earnings Per Share, DilutedUSD per share | 13.23Source | 15.51Source | 23.86Source | 21.18Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 908,000,000Source | 921,000,000Source | 928,000,000Source | 937,000,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 911,000,000Source | 929,000,000Source | 938,000,000Source | 950,000,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,700,000,000Source | 1,700,000,000Source | 1,600,000,000Source | 1,300,000,000Source |
| Capitalized Computer Software, AmortizationUSD | 1,700,000,000Source | 1,400,000,000Source | 1,200,000,000Source | 1,000,000,000Source |
| Costs and ExpensesUSD | 428,603,000,000Source | 367,991,000,000Source | 339,264,000,000Source | 295,727,000,000Source |
| Current Income Tax Expense (Benefit)USD | 3,642,000,000Source | 5,125,000,000Source | 6,213,000,000Source | 6,377,000,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 4,361,000,000Source | 4,099,000,000Source | 3,972,000,000Source | 3,400,000,000Source |
| Goodwill, Impairment LossUSD | 0Source | 0Source | 0Source | 0Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | 14,893,000,000Source | 28,264,000,000Source | — | — |
| Interest ExpenseUSD | 4,002,000,000Source | 3,906,000,000Source | 3,246,000,000Source | 2,092,000,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | 313,995,000,000Source | 264,185,000,000Source | 241,894,000,000Source | 210,842,000,000Source |
| Restructuring CostsUSD | 2,500,000,000Source | — | — | — |
Filing attachments
d947980dex41.htm · 8-K · 2025-06-20
EX-4.1 4 d947980dex41.htm EX-4.1 EX-4.1 EXHIBIT 4.1 UNITEDHEALTH GROUP INCORPORATED $500,000,000 4.400% Notes due June 15, 2028 Officers’ Certificate and Company Order Pursuant to the Indenture, dated as of February 4, 2008 (the “Indenture”), between UnitedHealth Group Incorporated, a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and resolutions adopted by the Company’s Board of Directors on February 24, 2023, this O…
Read attachment ↗d947980dex42.htm · 8-K · 2025-06-20
EX-4.2 5 d947980dex42.htm EX-4.2 EX-4.2 EXHIBIT 4.2 UNITEDHEALTH GROUP INCORPORATED $750,000,000 4.650% Notes due January 15, 2031 Officers’ Certificate and Company Order Pursuant to the Indenture, dated as of February 4, 2008 (the “Indenture”), between UnitedHealth Group Incorporated, a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and resolutions adopted by the Company’s Board of Directors on February 24, 2023, thi…
Read attachment ↗d947980dex43.htm · 8-K · 2025-06-20
EX-4.3 6 d947980dex43.htm EX-4.3 EX-4.3 EXHIBIT 4.3 UNITEDHEALTH GROUP INCORPORATED $1,000,000,000 5.300% Notes due June 15, 2035 Officers’ Certificate and Company Order Pursuant to the Indenture, dated as of February 4, 2008 (the “Indenture”), between UnitedHealth Group Incorporated, a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and resolutions adopted by the Company’s Board of Directors on February 24, 2023, this…
Read attachment ↗d947980dex44.htm · 8-K · 2025-06-20
EX-4.4 7 d947980dex44.htm EX-4.4 EX-4.4 EXHIBIT 4.4 UNITEDHEALTH GROUP INCORPORATED $750,000,000 5.950% Notes due June 15, 2055 Officers’ Certificate and Company Order Pursuant to the Indenture, dated as of February 4, 2008 (the “Indenture”), between UnitedHealth Group Incorporated, a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), and resolutions adopted by the Company’s Board of Directors on February 24, 2023, this O…
Read attachment ↗